The Cigna Group stock gains as 2026 outlook rises, risks persist

The Cigna Group reported stronger third-quarter operations on Thursday, November 5, 2026, and raised its full-year adjusted earnings outlook. AD HOC NEWS reported that management increased the minimum 2026 adjusted income-from-operations outlook by 0.15 US dollars per share to 30.60 US dollars.

Healthcare gains offset pharmacy pressure

Third-quarter revenue rose 6 percent year over year to 73.7 billion US dollars. Adjusted income from operations reached 2.1 billion US dollars, or 7.98 US dollars per share, compared with 7.83 US dollars a year earlier. Reported shareholders' net income fell because the prior-year period included an after-tax gain from a business sale.

Cigna Healthcare was the main operating growth driver. Adjusted revenue increased 9 percent to 11.7 billion US dollars, while adjusted pretax income rose 15 percent to 1.2 billion US dollars. Evernorth Health Services increased adjusted revenue 6 percent to 63.8 billion US dollars, but adjusted pretax income declined 4 percent to 1.8 billion US dollars.

Pharmacy Benefit Services earnings fell 22 percent to 765 million US dollars amid large client contract renewals and strategic investments. Specialty and Care Services partly offset the decline with 15 percent earnings growth to 1.1 billion US dollars. The company also plans to exit its Individual and Family Plans medical business on January 1, 2027, adding an execution milestone for investors.

Stock trades below prior Xetra close

The Cigna Group stock traded at 265.20 euros on Lang & Schwarz at 16:10 CET on Wednesday, November 11, 2026, 0.86 percent below the Xetra close of 267.50 euros on Tuesday, November 10.

The higher earnings floor supports the near-term outlook, but medical-cost trends and pharmacy-benefit execution remain central to valuation. Management also maintained the Evernorth full-year pretax earnings target of at least 6.9 billion US dollars and lifted the Cigna Healthcare floor to at least 4.6 billion US dollars.

US healthcare shares remain linked to the broader market backdrop of the S&P 500.

More news and analyses on The Cigna Group stock